Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metformin (MET) therapy exerts positive effects improving glucose tolerance and preventing the evolution toward diabetes in insulin resistant patients. It has been shown that adding MET to exercise training does not improve insulin sensitivity. The aim of this study was to determine the effect of MET and exercise training alone or in combination on maximal aerobic capacity and, as a secondary end-point on quality of life indexes in individuals with insulin resistance. METHODS: 75 insulin resistant patients were enrolled and subsequently assigned to MET (M), MET with exercise training (MEx), and exercise training alone (Ex). 12-weeks of supervised exercise-training program was carried out in both Ex and MEx groups. Cardiopulmonary exercise test and SF-36 to evaluate Health-Related Quality of Life (HRQoL) was performed at basal and after 12-weeks of treatment. RESULTS: Cardiopulmonary exercise test showed a significant increase of peak VO2 in Ex and MEx whereas M showed no improvement of peak VO2 (∆ VO2 [CI 95%] Ex +0.26 [0.47 to 0.05] l/min; ∆ VO2 MEx +0.19 [0.33 to 0.05] l/min; ∆ VO2 M -0.09 [-0.03 to -0.15] l/min; M vs E p < 0.01; M vs MEx p < 0.01; MEx vs Ex p = ns). SF-36 highlighted a significant increase in general QoL index in the MEx (58.3 ± 19 vs 77.3 ± 16; p < 0.01) and Ex (62.1 ± 17 vs 73.7 ± 12; p < 0.005) groups. CONCLUSIONS: We evidenced that cardiopulmonary negative effects showed by MET therapy may be counterbalanced with the combination of exercise training. Given that exercise training associated with MET produced similar effects to exercise training alone in terms of maximal aerobic capacity and HRQoL, programmed exercise training remains the first choice therapy in insulin resistant patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High-intensity training may be required for those on metformin to optimize aerobic capacity gains [[576], [577], [578]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [576]
Experimental — accuracy not yet measuredIn the citing paper
“High-intensity training may be required for those on metformin to optimize aerobic capacity gains [[576], [577], [578]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [576]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Exercise capacity and mortality among men referred for exercise testing
Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., & Atwood, J. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011858 · Cited by 4,114
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Principles of Exercise Testing and Interpretation.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-646 · Cited by 2,359
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., & Braun, B. (2010) · Diabetes Care · doi:10.2337/dc10-9990 · Cited by 1,955
AMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
Orchard, T. J., Temprosa, M., Goldberg, R., Haffner, S., Ratner, R., Marcovina, S., Fowler, S., & for the Diabetes Prevention Program Research Group (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-8-200504190-00009 · Cited by 948
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Targher, G., Alberiche, M., Bonadonna, R. C., & Muggeo, M. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1643 · Cited by 837
Insulin Resistance and Risk of Congestive Heart Failure
Ingelsson, E., Sundström, J., Ärnlöv, J., Zethelius, B., & Lind, L. (2005) · JAMA · doi:10.1001/jama.294.3.334 · Cited by 573
(2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181eeb61c · Cited by 567
Ware, J. E., Gandek, B., Kosinski, M., Aaronson, N. K., Apolone, G., Brazier, J., Bullinger, M., Kaasa, S., Leplège, A., Prieto, L., et al. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00108-5 · Cited by 560
Insulin-Resistant Cardiomyopathy
Witteles, R. M., & Fowler, M. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.021 · Cited by 351
Pathophysiological implications of insulin resistance on vascular endothelial function
Wheatcroft, S. B., Williams, I. L., Shah, A. M., & Kearney, M. T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00869.x · Cited by 306
Batandier, C., Guigas, B., Detaille, D., El-Mir, M., Fontaine, E., Rigoulet, M., & Leverve, X. M. (2006) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9003-8 · Cited by 279
Exercise capacity and mortality among men referred for exercise testing
Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., & Atwood, J. E. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00697-9 · Cited by 269
Principles of Exercise Testing and Interpretation
Wasserman, K., Hansen, J. E., Sue, D. Y., Whipp, B. J., & Froelicher, V. F. (1987) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-198704000-00014 · Cited by 237
Malin, S. K., Gerber, R., Chipkin, S. R., & Braun, B. (2012) · Diabetes Care · doi:10.2337/dc11-0925 · Cited by 229
Missing quality of life data in cancer clinical trials: serious problems and challenges
Bernhard, J., Cella, D. F., Coates, A. S., Fallowfield, L. J., Ganz, P. A., Moinpour, C. M., Mosconi, P., Osoba, D., Simes, R. J., & Hürny, C. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980315/15)17:5/7<679::aid-sim814>3.0.co;2-x · Cited by 216
Metformin improves endothelial function in patients with metabolic syndrome
VITALE, C., MERCURO, G., CORNOLDI, A., FINI, M., VOLTERRANI, M., & ROSANO, G. M. C. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01531.x · Cited by 164
Self-citationJadhav, S., Ferrell, W., Greer, I. A., Petrie, J. R., Cobbe, S. M., & Sattar, N. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.088 · Cited by 157
Mitochondrial metabolism and type-2 diabetes: a specific target of metformin
Leverve, X. M., Guigas, B., Détaille, D., Batandier, C., Koceir, E.-A., Chauvin, C., Fontaine, E. M., & Wiernsperger, N. F. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72792-x · Cited by 153
Sharoff, C. G., Hagobian, T. A., Malin, S. K., Chipkin, S. R., Yu, H., Hirshman, M. F., Goodyear, L. J., & Braun, B. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00517.2009 · Cited by 147
Addition of Metformin to a Lifestyle Modification Program in Adolescents with Insulin Resistance
Love‐Osborne, K., Sheeder, J. L., & Zeitler, P. S. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.01.018 · Cited by 137
Florez, H. J., Pan, Q., Ackermann, R. T., Marrero, D. G., Barrett-Connor, E. L., Delahanty, L. M., Kriska, A. M., Saudek, C. D., Goldberg, R. B., & Rubin, R. R. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2122-5 · Cited by 113
The Effect of Metformin on Insulin Resistance and Exercise Parameters in Patients with Heart Failure
Wong, A. K. F., Symon, R., AlZadjali, M. A., Ang, D. S. C., Ogston, S., Choy, A., Petrie, J. R., Struthers, A. D., & Lang, C. C. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs106 · Cited by 103
Metabolic remodelling in human heart failure
Tuunanen, H., & Knuuti, J. M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr052 · Cited by 91
Impact of metformin on peak aerobic capacity
Braun, B., Eze, P., Stephens, B. R., Hagobian, T. A., Sharoff, C. G., Chipkin, S. R., & Goldstein, B. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-144 · Cited by 83
Tapp, R. J., Dunstan, D. W., Phillips, P., Tonkin, A. M., Zimmet, P., & Shaw, J. E. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.03.012 · Cited by 78
Many Americans Have Pre-Diabetes and Should Be Considered for Metformin Therapy
Rhee, M. K., Herrick, K., Ziemer, D. C., Vaccarino, V., Weintraub, W. S., Narayan, K. M. V., Kolm, P., Twombly, J. G., & Phillips, L. S. (2010) · Diabetes Care · doi:10.2337/dc09-0341 · Cited by 68
Snehalatha, C., Mary, S., Selvam, S., Sathish Kumar, C. K., Shetty, S. B. A., Nanditha, A., & Ramachandran, A. (2009) · Diabetes Care · doi:10.2337/dc09-0676 · Cited by 64
Physical activity and health-related quality of life in individuals with prediabetes
Taylor, L., Spence, J. C., Raine, K. D., Plotnikoff, R. C., Vallance, J. K., & Sharma, A. M. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.04.011 · Cited by 48
Impact of modified glucose target and exercise interventions on vascular risk factors
Dasgupta, K., Grover, S. A., Costa, D. D., Lowensteyn, I., Yale, J., & Rahme, E. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.09.010 · Cited by 29
Dessalvi, C. C., Nocco, S., Piano, D., Deidda, M., Cossu, E., Baroni, M. G., & Mercuro, G. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-66 · Cited by 29
Self-citationMiyatake, N., Saito, T., Wada, J., Miyachi, M., Tabata, I., Matsumoto, S., Nishikawa, H., Makino, H., & Numata, T. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.11.008 · Cited by 20
Bethel, M. A., & Califf, R. M. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.09.122 · Cited by 19
Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population
Dessalvi, C. C., Nocco, S., Deidda, M., Cadeddu, F., Bina, A., Demuru, P., Cossu, E., Baroni, M. G., & Mercuro, G. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.04.113 · Cited by 13
Self-citationAMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.014 · Cited by 10
Relationship between high values of HOMA-IR and cardiovascular response to metformin
Dessalvi, C. C., Nocco, S., Deidda, M., Cadeddu, F., Bina, A., Demuru, P., Cossu, E., Baroni, M. G., & Mercuro, G. G. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.207 · Cited by 7
Self-citationEarly Ventricular Dysfunction in Type II Diabetes: Role of Metabolic Unbalance
Dessalvi, C. C. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s13-004 · Cited by 2
Research works printed but not linked: 1
- Cadeddu C Deidda M Nocco S Locci E Cossu E Baroni M Atzori L Mercuro G Effects of Metformin treatment on Myocardial and Endothelial functionin insulin resistance patients: a metabolomic study Diabetes Metab 2013 158 302 4
Cited by
AMPK in skeletal muscle function and metabolism
Kjøbsted, R., Hingst, J. R., Fentz, J., Foretz, M., Sanz, M., Pehmøller, C., Shum, M., Marette, A., Mounier, R., Treebak, J. T., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700442r · Cited by 496
Izquierdo, M., de Souto Barreto, P., Arai, H., Bischoff-Ferrari, H. A., Cadore, E. L., Cesari, M., Chen, L.-K., Coen, P. M., Courneya, K. S., Duque, G., et al. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100401 · Cited by 273
Impact of Metformin on Exercise-Induced Metabolic Adaptations to Lower Type 2 Diabetes Risk
Malin, S. K., & Braun, B. (2016) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000070 · Cited by 56
Mechanisms of aerobic exercise impairment in diabetes: a narrative review
Wahl, M. P., Scalzo, R. L., Regensteiner, J. G., & Reusch, J. E. B. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00181 · Cited by 44
Wheel running reduces high-fat diet intake, preference and mu-opioid agonist stimulated intake
Liang, N., Bello, N. T., & Moran, T. H. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.02.004 · Cited by 54
Metadata
- Authors
- Cadeddu, C., Nocco, S., Cugusi, L., Deidda, M., Bina, A., Fabio, O., Bandinu, S., Cossu, E., Baroni, M. G., & Mercuro, G.
- Affiliations
- University of Cagliari (IT)
- Venue
- Cardiovascular Diabetology
- Published
- 2014-05-15
- Volume
- 13
- Issue
- 1
- Pages
- 93-93
- ISSN
- 1475-2840 (ISSN-L)
- PMC
- PMC4030458
- OpenAlex
- W2143533366
- Cited by
- 32
- References
- 41
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 4 · 2016: 1 · 2015: 3
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- creativecommons.org/licenses/by/2.0 (vor)
- Locations
- Cardiovascular Diabetology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, public-domain)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion, cc-by)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, other-oa)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Keywords
- metformin, exercise training, insulin resistance, maximal aerobic capacity, peak oxygen uptake, health-related quality of life, cardiopulmonary exercise testing, SF-36, combination therapy, diabetes prevention
- MeSH terms
- Adult, Combined Modality Therapy, Exercise Test, Female, Humans, Hypoglycemic Agents, Insulin Resistance, Male, Metformin, Middle Aged, Prospective Studies, Quality of Life, Exercise, Single-Blind Method, Treatment Outcome, Exercise Tolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.